2026 Round Up campaign runs October 1 - 31 in stores nationwide, benefiting Impact One Breast Cancer Foundation
STAMFORD, Conn., Oct. 1, 2026 /CNW/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, is proud to kick off its annual Breast Cancer Action Month initiative. For the seventh consecutive year, Curaleaf is running its national at-register Round Up campaign, giving customers in every store the chance to round up their purchase, or donate $1 or $5, at checkout. This year's proceeds will support Impact One Breast Cancer Foundation, a nonprofit dedicated to providing prompt, hands-on support to people impacted by breast cancer.
Since launching the program in 2020, Curaleaf and its customers have raised and donated more than $600,000 combined for Breast Cancer Action Month causes, including over $75,000 raised last year alone. This year's campaign continues that momentum, running October 1 through October 31 in all Curaleaf states except Ohio, where round-up campaigns are not permitted under state regulations.
"Seven years and $600,000 are huge milestones for our Breast Cancer Action Month initiative," said Boris Jordan, Curaleaf Chairman and CEO. "Those milestones are what Rooted in Good looks like in practice, with our teams and customers working together to put real resources into the hands of people who need them. This October, we're proud to partner with Impact One whose work supports people at some of the hardest moments of a breast cancer diagnosis. Every dollar rounded up this month helps make sure no one faces that alone."
Impact One was founded by a close circle of women, led by breast cancer survivor and advocate Elizabeth Ayers-Cluff, after experiencing firsthand how few immediate, practical resources exist for people navigating a breast cancer diagnosis. The organization's mission is to provide prompt support and resources to those impacted by breast cancer, easing the financial and emotional burden of treatment and recovery.
"We're honored to partner with Curaleaf in our mission to connect with and support those impacted by breast cancer," said Ayers-Cluff. "Curaleaf's customers will be making a real difference in people's lives, and we're grateful to them and to the Curaleaf team for putting this cause in front of so many."
To learn more about Rooted in Good and Curaleaf's corporate social responsibility initiatives, please visit https://curaleaf.com/rooted-in-good.
About Curaleaf Holdings
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, Find, Dark Heart, and Anthem provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its unique distribution network throughout Europe, Canada and Australasia brings together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.
Forward Looking Statements
This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward-looking statements and information concerning Curaleaf's 2026 Breast Cancer Action Month initiative. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and uncertainties is discussed in the Company's Form 8-K dated August 5, 2026 together with the annual report on Form 10-K for the year ended December 31, 2025 and the quarterly report on Form 10-Q for the quarter ended March 31, 2026, attached as exhibits thereto, as well as the Form 10-Q for the quarter ended June 30, 2026, each of which documents have been filed on the Company's EDGAR profile at www.sec.gov/edgar and SEDAR+ profile at www.sedarplus.ca, and as described from time to time in documents filed by the Company with the U.S. Securities and Exchange Commission and the Canadian securities regulatory authorities. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Toronto Stock Exchange has not reviewed, approved or disapproved the content of this news release.
Investor Contact:
Curaleaf Holdings, Inc.
Camilo Lyon, Chief Investment Officer
IR@curaleaf.com
Media Contact:
MATTIO Communications
MattioCuraleaf@Mattio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/curaleaf-marks-seven-years-and-600-000-donated-for-breast-cancer-action-month-302896277.html
SOURCE Curaleaf Holdings, Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/October2026/01/c9134.html